Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2021-06-15
- Lead Sponsor
- Athens Medical Society
- Target Recruit Count
- 90
- Registration Number
- NCT04902183
- Locations
- 🇬🇷
3rd Department of Medicine, "Sotiria" Thoracic Diseases General Hospital of Athens, Athens, Attica, Greece
🇬🇷Attikon University Hospital, Athens, Attica, Greece
🇬🇷7th Respiratory Medicine Department, "Sotiria" Thoracic Diseases General Hospital of Athens, Athens, Attika, Greece
News
No news found